Skip to content

The effect of melatonin on night sleep quality in Emergency Medicine Residents

comparison between oral melatonin effect versus placebo on night sleep quqlity in Emergency Medicine residents of Tehran University of Medical Sciences after night shifts

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015112925286N1
Enrollment
48
Registered
2016-05-15
Start date
2016-05-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonorganic sleep disorders. Nonorganic sleep disorders

Interventions

Intervention 1: A group of residents treat with 3 mg tablets of melatonin one hour before bedtime on two consecutive nights after the second night shift and this intervention repeat two weeks later. I
Treatment - Drugs
Placebo
A group of residents treat with 3 mg tablets of melatonin one hour before bedtime on two consecutive nights after the second night shift and this intervention repeat two weeks later. In this study, pa
Another group of residents treat with placebo one hour before bedtime on two consecutive nights after the second night shift and this intervention repeat two weeks later. In this study, participants a

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Incllusion criteria: All of Emergency Medicine Residents of Tehran University during the time of testing peresent in the Emergency Department and have clinical shifts. they have 9-hour clinical shifts for two consecutive shifts from 7 am to 4 pm and two consecutive shifts from 3 pm to 12 pm, and two consecutive shifts from11 pm to 8 am. Exclusion criteria: Residents who their shift conditions on the model is not mentioned. Pregnant and nursing mother Residents; Residents with a history of alcohol; narcotics and psychogenic substances; benzodiazepines; hypnotics abuse; Residents with a history of psychiatric disorders or restless syndrome.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Drowsiness. Timepoint: the time of awakening at the morning of two consecutive days. Method of measurement: Based on KSS (Karolinnska Sleep Scale).;Fatigue. Timepoint: the time of awakening at the morning of two consecutive days. Method of measurement: Using VAS(Visual Analoug Scale).;Mood State. Timepoint: the time of awakening at the morning in the first study day and the end of study day. Method of measurement: Based on POMS(Prfile Of Mood States).

Secondary

MeasureTime frame
Sleep onset latency. Timepoint: The next morning. Method of measurement: per minutes.;Number of times of night awakening. Timepoint: The next morning. Method of measurement: The patient.;Morning insomnia. Timepoint: The next morning. Method of measurement: The patient.;Nightmare. Timepoint: The next morning. Method of measurement: The patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Masoumeh Vafaeian

Tehran University of Medical Sciences

mvafaeian@razi.tums.ac.ir+98 21 6690 4848

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026